BCHE and early-onset autosomal dominant Alzheimer disease: Systematic reviews and meta-analyses evaluating the efficacy of cholinesterase inhibitors (such as donepezil, rivastigmine, and galantamine) for MCI treatment have concluded that there is no convincing evidence that cholinesterase inhibitors have an effect on cognitive test scores or the progression of MCI to Alzheimer’s disease [5, 6].